Skip to main content
. 2019 Oct 16;11(10):1577. doi: 10.3390/cancers11101577

Table 5.

Type III ATX inhibitors based on their kinetic and crystallographic analysis.

graphic file with name cancers-11-01577-i017.jpg Type III Inhibitor PDB ID Activity (IC50) Reference
Inline graphic
7-α-hydroxycholesterol
5dlt undetermined [26]
Inline graphic
TUDCA
5dlw 10.4 µM [26]
Inline graphic
PAT-347
4zg7 0.3 nM [50]
Inline graphic
PAT-505
5kxa 2 nM [70]
Inline graphic
LM-Cpd 51
5lqq 81 nM [71]